SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-105232
Filing Date
2013-03-13
Accepted
2013-03-13 16:17:32
Documents
15
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d457406d10k.htm 10-K 1164010
2 EX-10.60 d457406dex1060.htm EX-10.60 14569
3 EX-10.61 d457406dex1061.htm EX-10.61 9416
4 EX-23.1 d457406dex231.htm EX-23.1 1934
5 EX-31.1 d457406dex311.htm EX-31.1 6422
6 EX-31.2 d457406dex312.htm EX-31.2 6617
7 EX-32.1 d457406dex321.htm EX-32.1 5809
14 GRAPHIC g457406g04a06.jpg GRAPHIC 42522
15 GRAPHIC g457406g34y93.jpg GRAPHIC 33702
  Complete submission text file 0001193125-13-105232.txt   7135535

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT snss-20121231.xml EX-101.INS 914878
9 XBRL TAXONOMY EXTENSION SCHEMA snss-20121231.xsd EX-101.SCH 69108
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20121231_cal.xml EX-101.CAL 71155
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20121231_def.xml EX-101.DEF 241919
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20121231_lab.xml EX-101.LAB 525403
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20121231_pre.xml EX-101.PRE 374023
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51531 | Film No.: 13687677
SIC: 2834 Pharmaceutical Preparations